This study provides novel evidence elucidating the involvement of PADI2 and its citrullination in osteoblast differentiation and function, thereby opening up new avenues for targeting bone diseases, including CCD and senile osteoporosis, in potential therapeutic interventions. Here, PADI2 is linked to cleidocranial dysplasia 1.